Crynodeb
- OCID:
- ocds-h6vhtk-05ea44
- Cyhoeddwyd gan:
- Cardiff University
- ID Awudurdod:
- AA0258
- Dyddiad cyhoeddi:
- 16 Ionawr 2026
- Dyddiad Cau:
- 30 Ionawr 2026
- Math o hysbysiad:
- UK4
- Mae ganddo ddogfennau:
- Yndi
- Wedi SPD:
- Nac Ydi
- Mae ganddo gynllun lleihau carbon:
- AMH
Crynodeb
The School of Medicine successfully applied for a UKRI grant to investigate in a randomised controlled trial (RCT), a new IMP (investigational medicinal product) called Triiodothyronine sulphate (T3S) in hypothyroid subjects with a gene difference in a thyroid related enzyme called deiodinase 2 (D2).We are looking for a CDMO to (i) Import and QP sign off T3S and matched placebo tablets obtained from Ardena, Pamplona, Spain who will manufacture these to GMP standards; (ii) over encapsulate commercially secured L-thyroxine (LT4 ) and matched placebo capsules; (iii) store T3S and matched placebo obtained from Ardena, and over encapsulated LT4 and matched placebo; (iv) label T3S, LT4 and respective placebo packs for distribution to trial subjects; (v) distribute T3S and matched placebo and over encapsulated LT4 and matched placebo packs to trial pharmacy (Royal Glamorgan Hospital, Wales).
Testun llawn y rhybydd
Cwmpas
Disgrifiad caffael
The School of Medicine successfully applied for a UKRI grant to investigate in a randomised controlled trial (RCT), a new IMP (investigational medicinal product) called Triiodothyronine sulphate (T3S) in hypothyroid subjects with a gene difference in a thyroid related enzyme called deiodinase 2 (D2).
We are looking for a CDMO to (i) Import and QP sign off T3S and matched placebo tablets obtained from Ardena, Pamplona, Spain who will manufacture these to GMP standards; (ii) over encapsulate commercially secured L-thyroxine (LT4 ) and matched placebo capsules; (iii) store T3S and matched placebo obtained from Ardena, and over encapsulated LT4 and matched placebo; (iv) label T3S, LT4 and respective placebo packs for distribution to trial subjects; (v) distribute T3S and matched placebo and over encapsulated LT4 and matched placebo packs to trial pharmacy (Royal Glamorgan Hospital, Wales).
Prif gategori
Gwasanaethau
Rhanbarthau cyflawni
- UKL22 - Cardiff and Vale of Glamorgan
Cyfanswm gwerth (amcangyfrif, heb gynnwys TAW)
421000 GBP to 421000GBP
Dyddiadau contract (amcangyfrif)
20 Ebrill 2026, 00:00yb to 11 Hydref 2027, 23:59yh
Gweithdrefn
Math o weithdrefn
Competitive flexible procedure
Cyfnod Tendro Llai
Qualifying planned procurement notice
A yw cyfanswm y gwerth uwchlaw'r trothwy?
Uwchben y trothwy
Lotiau
Wedi'i rannu'n 1 lot
Rhif lot: 1
Dosbarthiadau CPV
- 33600000 - Cynhyrchion fferyllol
- 73100000 - Gwasanaethau datblygu ymchwil a datblygu arbrofol
Rhanbarthau cyflawni
- UKL22 - Cardiff and Vale of Glamorgan
Gwerth lot (amcangyfrif)
421000 GBP Heb gynnwys TAW
421000 GBP Gan gynnwys TAW
Cynaladwyedd
Busnesau bach a chanolig (BBaCh)
Dyddiad cychwyn y contract (amcangyfrif)
20 Ebrill 2026, 00:00yb
Dyddiad diwedd y contract (amcangyfrif)
11 Hydref 2027, 23:59yh
Cyfranogiad
Amodau cymryd rhan
Relevant professional accreditations - further detail found in Tender Pack
Meini prawf dyfarnu
Math: quality
Enw
Quality
Pwysiad: 60.00
Math o bwysoli: percentageExact
Math: quality
Enw
Responsible Procurement
Pwysiad: 10.00
Math o bwysoli: percentageExact
Math: price
Enw
Pricing
Pwysiad: 30.00
Math o bwysoli: percentageExact
Cyflwyno
Dyddiad cau ar gyfer cyflwyno tendr
30 Ionawr 2026, 23:59yh
Dyddiad cau ar gyfer yr ymchwiliad
28 Ionawr 2026, 23:59yh
Dyddiad dyfarnu'r contract
30 Mawrth 2026, 23:59yh
Cyfeiriad cyflwyno ac unrhyw gyfarwyddiadau arbennig
NDAs are to be returned to the following email addresses - rower4@cardiff.ac.ukprocurement@cardiff.ac.ukRegistration and access to the tender is via our portal - https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
A ellir cyflwyno tendrau yn electronig?
Oes
Ieithoedd y gellir eu defnyddio ar gyfer cyflwyno
Dogfennau
Math o ddogfen
Dogfennau bidio
Disgrifiad
PLEASE NOTE - Returning of a SIGNED COPY of the attached NDA is required to gain access to the tender on our portal. Please ensure an NDA is sent to the below email addresses without delay to allow us to add your organisation to the tender activity. NDAs returned per the linked PPN UK4 notice will automatically qualify for access to this tender, a second NDA for those who have already returned an NDA is not required.
Once received, you will be added to the portal to review documentation and submit a bid. Please note, we can only add organisations who have an account on our portal, please ensure you have registered, otherwise we will be unable to add you until this is done.
Return of NDA -
rower4@cardiff.ac.uk
procurement@cardiff.ac.uk
Portal -
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
Math o ddogfen
Dogfennau bidio
Math o ddogfen
Upon return of the attached NDA, and registration on or Portal, prospective bidders will have access to all documents on our E-tender portal InTend. Please use the below link to register and access said documents once added to the tender event -
https://in-tendhost.co.uk/cardiffuniversity/aspx/Home
Math o ddogfen
Gwrthdaro buddiannau
Codio
Categorïau nwyddau
| ID |
Teitl
|
Prif gategori
|
|
Nid oes unrhyw gategorïau nwyddau ar gyfer yr hysbysiad hwn.
|
Lleoliadau Dosbarthu
| ID |
Disgrifiad
|
| 1022 |
Caerdydd a Bro Morgannwg |
Teulu dogfennau
|
Manylion hysbysiad
|
- Dyddiad cyhoeddi:
- 27 Tachwedd 2025
- Dyddiad Cau:
- 13 Ionawr 2026 01:00
- Math o hysbysiad:
- UK3
- Fersiwn:
- 1
- Enw Awdurdod:
- Cardiff University
|
- Dyddiad cyhoeddi:
- 16 Ionawr 2026
- Dyddiad Cau:
- 30 Ionawr 2026 23:59
- Math o hysbysiad:
- UK4
- Fersiwn:
- 1
- Enw Awdurdod:
- Cardiff University
|
Ynglŷn â'r prynwr
- Prif gyswllt:
- n/a
- Cyswllt gweinyddol:
- n/a
- Cyswllt technegol:
- n/a
- Cyswllt arall:
- n/a
Dogfennau Ychwanegol
Mae'r dogfennau ychwanegol canlynol wedi'u hatodi i'r hysbysiad hwn. I gael y dogfennau hyn, dewiswch enwau'r ffeiliau unigol isod.
Dogfennau cyfredol
docx29.68 KB
Gofyn am fformat gwahanol.
Dogfennau wedi'u disodli
Nid oes unrhyw fersiynau blaenorol o'r dogfennau hyn